Seth Thacker

4PUBLICATIONS
44CO-AUTHORS
GlycoconjugatesInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products.

Jennifer K Lee, Ha-Na Lee, Sudhir Agrawal

|Jan 09, 2026
Multiplexed Immunophenotyping for Innate Activation Assessment Detects Single-Cell Responses to Immunomodulatory Nucleic Acid Impurities in Therapeutics.

Joseph A Balsamo, Mirian Mendoza, Logan Kelly-Baker

|Dec 20, 2024
Cell-Based Assays to Detect Innate Immune Response Modulating Impurities: Application to Biosimilar Insulin.

Cheng Her, Seth Thacker, Joseph Balsamo

|Feb 29, 2020
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.

Seth G Thacker, Ian L McWilliams, Beatrice Bonnet

Pageof 1

Frequent Collaborators

3 joint publications

Daniela Verthelyi

2 joint publications

Joseph A Balsamo

2 joint publications

Mirian Mendoza

2 joint publications

Logan Kelly-Baker